Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Carisoprodol: update on abuse potential and legal status.

Reeves RR, Burke RS, Kose S.

South Med J. 2012 Nov;105(11):619-23. doi: 10.1097/SMJ.0b013e31826f5310. Review.

PMID:
23128807
2.

Carisoprodol: abuse potential and withdrawal syndrome.

Reeves RR, Burke RS.

Curr Drug Abuse Rev. 2010 Mar;3(1):33-8. Review.

PMID:
20088817
3.

Carisoprodol legal status and patterns of abuse.

Fass JA.

Ann Pharmacother. 2010 Dec;44(12):1962-7. doi: 10.1345/aph.1P339. Epub 2010 Nov 9. Review.

PMID:
21062909
4.

Carisoprodol (Soma): a new and cautious perspective on an old agent.

Littrell RA, Hayes LR, Stillner V.

South Med J. 1993 Jul;86(7):753-6. Review.

PMID:
8322081
6.

Principles of assessment of abuse liability: US legal framework and regulatory environment.

Rocha BA.

Behav Pharmacol. 2013 Sep;24(5-6):403-9. doi: 10.1097/FBP.0b013e328363d163. Review.

PMID:
23820327
7.

Carisoprodol - Effects on Human Performance and Behavior.

Robertson MM, Marinetti LJ.

Forensic Sci Rev. 2003 Jan;15(1):1-9. Review.

PMID:
26256591
8.

Carisoprodol Therapy and CYP2C19 Genotype.

Dean L.

In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2017 Apr 4.

9.

Social and legal factors related to drug abuse in the United States and Japan.

Greberman SB, Wada K.

Public Health Rep. 1994 Nov-Dec;109(6):731-7. Review.

10.

Muscle relaxants for pain management in rheumatoid arthritis.

Richards BL, Whittle SL, Buchbinder R.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922. doi: 10.1002/14651858.CD008922.pub2. Review.

PMID:
22258993
11.

Substance abuse and control in the United States: ethical and legal issues.

Newcomb MD.

Soc Sci Med. 1992 Aug;35(4):471-9. Review.

PMID:
1519100
12.

Barcelona meeting on clinical testing of drug abuse liability: consensus statement and recommendations.

[No authors listed]

Br J Addict. 1991 Dec;86(12):1527-8. Review. No abstract available.

PMID:
1786481
13.

A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States.

Calderon SN, Klein M.

Neuropharmacology. 2014 Dec;87:97-103. doi: 10.1016/j.neuropharm.2014.04.001. Epub 2014 Apr 12. Review.

PMID:
24727212
14.

NEWER DRUGS IN THE TREATMENT OF HEADACHE.

FRIEDMAN AP.

Med Clin North Am. 1964 Mar;48:445-57. Review. No abstract available.

PMID:
14149244
15.

Legally high? Legal considerations of Salvia divinorum.

Griffin OH, Miller BL, Khey DN.

J Psychoactive Drugs. 2008 Jun;40(2):183-91. Review.

PMID:
18720668
16.

Volatile substance abuse in the United Kingdom.

Ramsey J, Taylor J, Anderson HR, Flanagan RJ.

NIDA Res Monogr. 1995;148:205-49. Review. No abstract available.

PMID:
8929892

Supplemental Content

Support Center